Search

everythinglearnresearchcommunity

for

Search:↓

Certain genetic variations in the SHBG gene are linked to an increased or decreased risk of PCOS in Mediterranean women.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

The gene Foxn1 is important for hair growth, and understanding it may lead to new alopecia treatments.

Melatonin affects many body functions beyond sleep by interacting with specific receptors in various tissues.

Using anabolic androgenic steroids can cause serious, lasting health problems in many parts of the body.

Targeted siRNA therapy may be a promising treatment for KID syndrome by reducing mutant gene expression and improving cell communication.

Low vitamin D receptor levels found in hair loss patients; topical vitamin D treatment suggested.

MendelVar is a tool that helps identify important genes by combining GWAS data with Mendelian disease information.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

Testosterone and its metabolites affect brain functions and could help treat neurological disorders.

Molecular diagnostics help identify genetic defects causing endocrine diseases, improving diagnosis and treatment options.

AGA affects many, progresses differently, and early treatment is crucial.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

DHT, a testosterone byproduct, causes male pattern baldness.

Male pattern baldness involves genetics, hormones, and needs better treatments.

Right hand finger ratio may predict male hair loss.

Genetic data can predict male-pattern baldness with moderate accuracy, especially for early-onset cases in some European men.

Balding and low testosterone increase risk of urinary stones.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

New genes linked to male pattern baldness were found on chromosome 20p11.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Hair loss in men treated best with early medication or transplant, new treatments researched.

Premature balding in some men may be linked to altered hormones, but it's not the male equivalent to polycystic ovary syndrome or metabolic syndrome.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

5α reductase type 2 enzyme mutation and oxidative stress may increase androgenetic alopecia risk in Egyptians.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.